Siberian Medical Review : Impact Factor & More
eISSN: 2500-0136pISSN: 1819-9496
Share this on:
Key Metrics
H-Index 
2
SJR
Q4Medicine (miscellaneous)
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Siberian Medical Review Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Krasnoyarsk State Medical University |
Planning to publish in Siberian Medical Review ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Siberian Medical Review
The neurobiology of survivorship: Cognitive consequences of modern oncology
- 22 Jun 2026
- Neuro-Oncology Advances
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab
- 9 Jun 2026
- Neuro-Oncology Advances
Sensitivity and specificity of cerebrospinal fluid placental alkaline phosphatase in germinoma: An 8 pg/mL threshold
- 5 Jun 2026
- Neuro-Oncology Advances
A new method for optimal placement of tumor treating fields electrodes
- 3 Jun 2026
- Neuro-Oncology Advances
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
- 2 Jun 2026
- Neuro-Oncology Advances
Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide
- 29 May 2026
- Neuro-Oncology Advances
The neurobiology of survivorship: Cognitive consequences of modern oncology
- 22 Jun 2026
- Neuro-Oncology Advances
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab
- 9 Jun 2026
- Neuro-Oncology Advances
Sensitivity and specificity of cerebrospinal fluid placental alkaline phosphatase in germinoma: An 8 pg/mL threshold
- 5 Jun 2026
- Neuro-Oncology Advances
A new method for optimal placement of tumor treating fields electrodes
- 3 Jun 2026
- Neuro-Oncology Advances
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
- 2 Jun 2026
- Neuro-Oncology Advances
Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide
- 29 May 2026
- Neuro-Oncology Advances
FAQs on Siberian Medical Review
How many articles did Siberian Medical Review publish last year? 
What is the eISSN & pISSN for Siberian Medical Review?
What is the H Index for Siberian Medical Review ?
What is the SJR for Siberian Medical Review?
Who is the publisher of Siberian Medical Review?
